Pages that link to "Q34168385"

The following pages link to Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review (Q34168385):

Displaying 22 items.

• Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist (Q33558075) (← links)
• Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes (Q33573537) (← links)
• Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide (Q34480831) (← links)
• Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors (Q35062472) (← links)
• Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence (Q35162317) (← links)
• Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus (Q36576871) (← links)
• Are sulfonylureas passé? (Q36640590) (← links)
• Impact of therapeutic advances on hypoglycaemia in type 2 diabetes (Q37071750) (← links)
• Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes (Q37314518) (← links)
• In vivo efficacy of HD0471953: a novel GPR119 agonist for the treatment of type 2 diabetes mellitus (Q37412882) (← links)
• Pharmacokinetic evaluation of atorvastatin and sitagliptin in combination for the treatment of type 2 diabetes (Q38010243) (← links)
• Optimal utilisation of sulphonylureas in resource-constrained settings (Q38213126) (← links)
• GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes (Q39690535) (← links)
• Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes. (Q39775206) (← links)
• Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs (Q40963671) (← links)
• Synthesis of tryptoline-3-carboxylic Acid derivatives a novel antidiabetic agent (Q42155492) (← links)
• Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents (Q44555625) (← links)
• Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1α)-deficient mice (Q44643518) (← links)
• Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial (Q44953741) (← links)
• Frequency of (, and ) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin (Q64075045) (← links)
• [Childhood-onset diabetes treated with sulphonylureas] (Q83156787) (← links)
• Characteristics of Patients With Sulphonurea-Induced Hypoglycemia (Q83749030) (← links)